Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
wntresearch
-
search results
If you're not happy with the results, please do another search
WntResearch plummets after results
20 September, 2024
Investing in life science: From Seed to Success 2024
16 September, 2024
WntResearch’s CEO: “Aiming for an agreement”
27 August, 2024
BioStock Global Forum 2024
3 June, 2024
WntResearch’s CEO: “If the effect is confirmed, there are good opportunities...
8 May, 2024
WntResearch’s new CEO comments on his first month in the position
27 March, 2024
Resigning CEO on the future of WntResearch: “It will be exciting...
1 March, 2024
U.S. biotechs raise more capital
20 February, 2024
WntResearch’s CEO: “In a better position than ever”
21 November, 2023
All sessions from BioStock Life Science Fall Summit 2023
30 October, 2023
Video from day 2 of BioStock Life Science Fall Summit 2023
27 October, 2023
WntResearch recruits first patient in restart of NeoFox
20 October, 2023
New patent strengthens WntResearch
6 October, 2023
Watch the interviews from BioStock Investor Meeting!
26 September, 2023
Watch the presentations from BioStock Investor Meeting!
22 September, 2023
WntResearch hopes for in-depth talks about Foxy-5
23 August, 2023
New study plan approved for WntResearch’s phase II study
14 July, 2023
WntResearch receives attention for results with Foxy-5 in AML
29 June, 2023
Co-founder on WntResearch’s NeoFox observations
5 June, 2023
The BioStock Life Science Spring Summit 2023 goes live today
30 May, 2023
Funding in focus for WntResearch
10 May, 2023
WntResearch’s CEO on the option program and the NeoFox study
27 March, 2023
BioStock Investor Meeting starts today at 10.00
16 March, 2023
BioStock Life Science Summit 2023
22 February, 2023
Continued study focus for WntResearch
13 February, 2023
BioStock Investor Meeting 2023
10 February, 2023
VILDA – new network for female leaders in life science
16 January, 2023
WntResearch on the revised study plan for the NeoFox-study
9 December, 2022
Watch the BioStock Life Science Fall Summit!
8 December, 2022
The 5 best life science stocks so far in 2022
3 October, 2022
BioStock Investor Meeting: Interview with WntResearch
28 September, 2022
BioStock Investor Meeting: WntResearch presents
23 September, 2022
Brighter days for listed biotech companies
25 August, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
BioStock Investor Meeting, September 14
15 August, 2022
WntResearch advances recruitment and initiates research collaboration
4 July, 2022
WntResearch’s new CEO on her background and the journey ahead
27 June, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
WntResearch heads into spring with strengthened team
30 May, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
New CEO and continued patient recruitment for WntResearch
22 February, 2022
WntResearch’s Foxy-5 shows potential in leukaemia
4 January, 2022
WntResearch to focus on patient recruitment
7 December, 2021
WntResearch focuses on recruitment of patients and new CEO
9 September, 2021
WntResearch reaches full operations again in NeoFox study
7 July, 2021
WntResearch starts 2020 with study approval in Hungary
6 July, 2021
Wnt follows the authorities’ advice and pauses recruitment to phase II...
5 July, 2021
WntResearch’s CEO comments on the oversubscribed rights issue
5 July, 2021
WntResearch continues towards phase II results
4 July, 2021
CombiGene’s new Chairman on visions for the future
4 July, 2021
WntResearch provides update concerning phase II-study
3 July, 2021
Aptahem’s founder is back – now as Chairman of the Board
3 July, 2021
WntResearch’s new CEO on joining the company and the Phase II...
3 July, 2021
Stayble Therapeutics elects new Chairman of the Board
3 June, 2021
WntResearch increases the focus on Foxy-5
12 February, 2021
A triplet of pioneers in fourth round of presentations at BLSS...
1 November, 2019
